Management patterns and predictors of mortality among US patients with cancer hospitalized for malignant bowel obstruction

被引:48
|
作者
Alese, Olatunji B. [1 ]
Kim, Sungjin [2 ]
Chen, Zhengjia [2 ]
Owonikoko, Taofeek K. [1 ]
El-Rayes, Bassel F. [1 ]
机构
[1] Emory Univ, Winship Canc Inst, Dept Hematol & Oncol, Div Gastrointestinal Oncol, Atlanta, GA 30322 USA
[2] Emory Univ, Dept Biostat, Atlanta, GA 30322 USA
关键词
malignant bowel obstruction; patients with cancer; hospital data; predictors of survival; treatment modality; INTESTINAL-OBSTRUCTION; SURGICAL-MANAGEMENT; SURVIVAL; SURGERY; DISEASE;
D O I
10.1002/cncr.29297
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUNDMalignant bowel obstruction affects an estimated 3% to 15% of patients with cancer, with a mean survival of <4 weeks reported in patients with inoperable malignant bowel obstruction. In the current study, the authors assessed predictors of survival and the influence of treatment modality in US patients with cancer who were hospitalized for malignant bowel obstruction. METHODSAll the US cancer patients hospitalized with malignant bowel obstruction in 2006 and 2010 were included. Data were obtained from the Nationwide Inpatient Sample provided by the Agency for Healthcare Research and Quality. Malignant bowel obstruction diagnoses and treatment variables were identified using Clinical Classifications Software codes based on International Classification of Diseases, Ninth Revision and Current Procedural Terminology codes. Univariate and multivariate analyses were performed with a logistic model, weighted chi-square test, and a generalized linear model. RESULTSThe authors identified 942,014 and 1,103,528 hospitalizations for malignant bowel obstruction in 2006 and 2010, respectively. Medical management, upper gastrointestinal obstruction, health insurance coverage, and obesity were found to be significantly associated with better hospital survival. Multivariate analysis also demonstrated significantly increased odds of death with male sex, advanced age, AJCC stage IV disease, multiple comorbid conditions (except acquired immunodeficiency syndrome), and weight loss. There were no significant differences with stratification based on the location and etiology of the obstruction (primary tumor vs metastatic). CONCLUSIONSMalignant bowel obstruction is a common cause of death in hospitalized patients with advanced cancer in the United States. The odds of death are especially high in older patients and those with concurrent medical illnesses. Lack of insurance coverage, significant weight loss, and surgical management also appear to be associated with higher mortality in this population. Cancer 2015;121:1772-1778. (c) 2015 American Cancer Society. Malignant bowel obstruction is a common cause of death in hospitalized patients with advanced cancer. The current study characterizes predictors of survival and the influence of treatment modality in these patients.
引用
收藏
页码:1772 / 1778
页数:7
相关论文
共 50 条
  • [21] Factors Predicting Readmission and Mortality in Patients Admitted for Malignant Bowel Obstruction
    Xu, Nova
    Sun, Beatrice J.
    Yue, Tiffany M.
    Lee, Byrne
    AMERICAN SURGEON, 2024, 90 (10) : 2570 - 2576
  • [22] Contemporary Management of Malignant Bowel Obstruction
    Onyiego, Alexandra
    Maykel, Justin
    CLINICS IN COLON AND RECTAL SURGERY, 2025,
  • [23] Management of malignant bowel obstruction Reply
    Krouse, Robert S.
    Anderson, Garnet L.
    Arnold, Kathryn B.
    Sun, Virginia
    Secord, Angeles Alvarez
    Deutsch, Gary B.
    Deneve, Jeremiah L.
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2024, 9 (01): : 15 - 15
  • [24] Considerations in the Management of Malignant Bowel Obstruction
    Yeo, Caitlin T.
    Merchant, Shaila J.
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2021, 30 (03) : 461 - 474
  • [25] Palliative management of malignant bowel obstruction
    Ripamonti, C
    Bruera, E
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2002, 12 (02) : 135 - 143
  • [26] Predictors of Mortality Among Hospitalized Patients With Chronic Constrictive Pericarditis
    Etuk, Aniekeme S.
    Jackson, Inimfon
    Olanipekun, Olalekan
    Ajenifuja, Adeniyi A.
    Olubowale, Olusola
    Jacob, Mina
    CIRCULATION, 2023, 148
  • [27] Octreotide prescribing patterns in the palliation of symptomatic inoperable malignant bowel obstruction patients at a single US academic hospital
    Michael Hwang
    Rosene Pirrello
    Minya Pu
    Karen Messer
    Eric Roeland
    Supportive Care in Cancer, 2013, 21 : 2817 - 2824
  • [28] Octreotide Prescribing Patterns in the Palliation of Symptomatic Inoperable Malignant Bowel Obstruction Patients at a Single US Academic Hospital
    Roeland, Eric
    Hwang, Michael
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2013, 45 (02) : 373 - 374
  • [29] Octreotide prescribing patterns in the palliation of symptomatic inoperable malignant bowel obstruction patients at a single US academic hospital
    Roeland, Eric
    Hwang, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [30] Octreotide prescribing patterns in the palliation of symptomatic inoperable malignant bowel obstruction patients at a single US academic hospital
    Hwang, Michael
    Pirrello, Rosene
    Pu, Minya
    Messer, Karen
    Roeland, Eric
    SUPPORTIVE CARE IN CANCER, 2013, 21 (10) : 2817 - 2824